{"url_path":"/sec/zeox/8-k/2026-06-09/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-09","source_url":"https://www.sec.gov/Archives/edgar/data/1557376/0001829126-26-006218-index.html","accession_number":"0001829126-26-006218","cik":"0001557376","ticker":"ZEOX","issuer_name":"Zeo ScientifiX, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1557376/0001829126-26-006218-index.html","primary_entity_key":"0001557376","primary_entity_name":"Zeo ScientifiX, Inc."},"word_count":52,"has_tables":true,"body_markdown":"**Item 8.01 Other Events.**\n\n \n\nOn June 9, 2026, ZEO issued a press release announcing\nthe expansion of its Medical Advisory Board with the addition of nine physicians and scientific innovators across key disciplines in regenerative\nand longevity medicine.\n\n \n\nA copy of the press release is included as **Exhibit\n99.1 **to this Report."}